Prothena Corporation PLC
PRTA8.180USD
+0.120+1.49%
종가 09/18, 16:00（ET）시세는 15분 지연됩니다
440.30M시가총액
손실P/E TTM
자세한 내용은 Prothena Corporation PLC 회사
Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company’s pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a range of other neurodegenerative diseases. Its clinical programs include birtamimab for the potential treatment of AL amyloidosis, prasinezumab for the potential treatment of Parkinson’s disease, NNC6019/PRX004 for the potential treatment of ATTR amyloidosis, and PRX005 and PRX012 for the potential treatment of Alzheimer’s disease.
회사 정보
종목 코드 PRTA
회사 이름Prothena Corporation PLC
상장일Dec 21, 2012
CEODr. Gene G. Kinney, Ph.D.
직원 수163
유형Ordinary Share
회계 연도 종료Dec 21
주소77 Sir John Rogerson's Quay, Block C
도시DUBLIN
증권 거래소NASDAQ Global Select Consolidated
국가Ireland
우편 번호D02 VK60
전화35312362500
웹사이트https://www.prothena.com/
종목 코드 PRTA
상장일Dec 21, 2012
CEODr. Gene G. Kinney, Ph.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Brandon S. Smith
Mr. Brandon S. Smith
Chief Operating Officer
Chief Operating Officer
130.00K
--
Dr. Wagner M. Zago, Ph.D.
Dr. Wagner M. Zago, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
85.00K
--
Dr. Dennis J. Selkoe, M.D.
Dr. Dennis J. Selkoe, M.D.
Independent Director
Independent Director
4.21K
--
Mr. Richard T. Collier
Mr. Richard T. Collier
Independent Director
Independent Director
1.22K
--
Dr. Lars G. Ekman, M.D., Ph.D.
Dr. Lars G. Ekman, M.D., Ph.D.
Chairman Emeritus
Chairman Emeritus
243.00
--
Mr. Daniel G. Welch
Mr. Daniel G. Welch
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Shane M. Cooke
Mr. Shane M. Cooke
Independent Director
Independent Director
--
--
Ms. Karin L. Walker, CPA
Ms. Karin L. Walker, CPA
Chief Accounting Officer
Chief Accounting Officer
--
--
Ms. Paula K. Cobb
Ms. Paula K. Cobb
Independent Director
Independent Director
--
--
Ms. Helen S. Kim
Ms. Helen S. Kim
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Brandon S. Smith
Mr. Brandon S. Smith
Chief Operating Officer
Chief Operating Officer
130.00K
--
Dr. Wagner M. Zago, Ph.D.
Dr. Wagner M. Zago, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
85.00K
--
Dr. Dennis J. Selkoe, M.D.
Dr. Dennis J. Selkoe, M.D.
Independent Director
Independent Director
4.21K
--
Mr. Richard T. Collier
Mr. Richard T. Collier
Independent Director
Independent Director
1.22K
--
Dr. Lars G. Ekman, M.D., Ph.D.
Dr. Lars G. Ekman, M.D., Ph.D.
Chairman Emeritus
Chairman Emeritus
243.00
--
Mr. Daniel G. Welch
Mr. Daniel G. Welch
Independent Chairman of the Board
Independent Chairman of the Board
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Tue, Aug 19
마지막 업데이트: Tue, Aug 19
주주
주주 유형
주주
주주
비율
Fidelity Management & Research Company LLC
14.68%
Scully (William P)
9.94%
Fennell (Todd W.)
8.08%
Adar1 Capital Management LLC
6.27%
BlackRock Institutional Trust Company, N.A.
5.80%
기타
55.23%
주주
주주
비율
Fidelity Management & Research Company LLC
14.68%
Scully (William P)
9.94%
Fennell (Todd W.)
8.08%
Adar1 Capital Management LLC
6.27%
BlackRock Institutional Trust Company, N.A.
5.80%
기타
55.23%
주주 유형
주주
비율
Investment Advisor
35.21%
Hedge Fund
25.21%
Individual Investor
19.25%
Investment Advisor/Hedge Fund
15.34%
Research Firm
3.20%
Pension Fund
0.42%
Bank and Trust
0.23%
Sovereign Wealth Fund
0.11%
Insurance Company
0.03%
기타
1.01%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
460
51.33M
95.35%
-19.91M
2025Q1
472
64.29M
119.45%
-7.39M
2024Q4
479
65.24M
121.19%
+239.99K
2024Q3
476
59.39M
110.43%
-5.39M
2024Q2
479
58.48M
108.76%
-4.67M
2024Q1
472
60.86M
113.29%
-264.94K
2023Q4
474
56.64M
105.77%
-2.21M
2023Q3
476
55.90M
104.65%
-1.73M
2023Q2
475
55.02M
104.46%
-3.12M
2023Q1
464
54.98M
104.68%
-658.88K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Fidelity Management & Research Company LLC
7.94M
14.75%
-129.91K
-1.61%
Mar 31, 2025
Scully (William P)
5.61M
10.42%
-36.34K
-0.64%
Mar 31, 2025
Fennell (Todd W.)
4.59M
8.53%
-54.34K
-1.17%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.29M
6.1%
-61.73K
-1.84%
Mar 31, 2025
Armistice Capital LLC
2.20M
4.08%
-40.00K
-1.79%
Mar 31, 2025
The Vanguard Group, Inc.
1.26M
2.34%
-134.57K
-9.65%
Mar 31, 2025
Palo Alto Investors LP
1.66M
3.08%
-78.23K
-4.50%
Mar 31, 2025
Federated MDTA LLC
541.76K
1.01%
-196.82K
-26.65%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Sep 6
마지막 업데이트: Sat, Sep 6
이름
비율
Schwab U.S. Small-Cap ETF
0%
Federated Hermes MDT Small Cap Core ETF
0%
ALPS Medical Breakthroughs ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Biotechnology ETF
0%
WisdomTree US SmallCap Fund
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 Growth ETF
0%
더 보기
Schwab U.S. Small-Cap ETF
비율0%
Federated Hermes MDT Small Cap Core ETF
비율0%
ALPS Medical Breakthroughs ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
iShares Russell 2000 ETF
비율0%
iShares Biotechnology ETF
비율0%
WisdomTree US SmallCap Fund
비율0%
iShares Russell 2000 Value ETF
비율0%
iShares Russell 2000 Growth ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
